Oliver trained as a Pharmacologist, but had an innate passion to follow his family heritage into the entrepreneurial world of business.
After working in commercial roles for GlaxoSmithKline, he was awarded a place of the fast track management programme for Smith Group, a FTSE 100. Projects included supply chain re-engineering for John Crane gas seals and the development of a new product for Smiths Medical with potential UK sales of £16million.
Other large corporate experience is with Stryker, where he helped develop a cloud based e-Healthcare tool to automate implant sizing and provide marketing tools for surgeons.
The ex-International President of J&J approached Oliver to help launch the first generic medical device manufacturer, aiming to disrupt this mature $450billion industry. He was integral in funding negotiations, leading lobby & policy strategy and global expansion. This was later named by a prominent UK Surgeon as "the biggest thing to happen to orthopaedics in 20 years".
Simultaneously, Oliver co-founded Amodisc with Ad Gandhe- engaging medical trainees & trainers through remote training tools.
Alongside being a panel member on groups such as the NHS Academic Health Sciences Networks, Oliver is a mentor on the NHS England Clinical Entrepreneur Programme and sits on the Board of companies ranging from AI, to operational workflow, diagnostics and mental health.